Investigational Drug Information for Proflavine
✉ Email this page to a colleague
What is the drug development status for Proflavine?
Proflavine is an investigational drug.
There have been 17 clinical trials for Proflavine.
The most recent clinical trial was a Phase 2 trial.
The most common disease conditions in clinical trials are Neoplasms, Barrett Esophagus, and Uterine Cervical Neoplasms. The leading clinical trial sponsors are M.D. Anderson Cancer Center, Anandasabapathy, Sharmila, M.D., and William Marsh Rice University.
Summary for Proflavine
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 3,937 |
| WIPO Patent Applications | 1,053 |
| Japanese Patent Applications | 1,343 |
| Clinical Trial Progress | Phase 2 (1969-12-31) |
| Vendors | 57 |
Recent Clinical Trials for Proflavine
| Title | Sponsor | Phase |
|---|---|---|
| Precision Optical Guidance for Oral Biopsy | National Institute of Dental and Craniofacial Research (NIDCR) | N/A |
| Precision Optical Guidance for Oral Biopsy | M.D. Anderson Cancer Center | N/A |
| Acceptability and Performance of a Mobile Optical Biopsy Technology for Gastrointestinal Cancer Screening | Baylor College of Medicine | Phase 2 |
Clinical Trial Summary for Proflavine
Top disease conditions for Proflavine
Top clinical trial sponsors for Proflavine
US Patents for Proflavine
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
